Home ETF List About

Portfolio Holdings Detail for ISIN IE00BJ5JNZ06
Stock Name / FundiShares MSCI World Health Care Sector ESG UCITS ETF
IssuerBlackrock
Entity holding fund iShares V Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF TickerCBUF.DE(EUR) CXE
ETF TickerWHCS.AS(USD) CXE
ETF TickerWHCS.MI(EUR) CXE
ETF TickerWHCS(EUR) ETF Plus

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares MSCI World Health Care Sector ESG UCITS ETF LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-11-12 (Wednesday)61,747USD 62,844,862USD 62,844,862
2025-11-11 (Tuesday)61,747USD 61,044,319LLY holding increased by 1357199USD 61,044,3190USD 1,357,199 USD 988.62 USD 966.64
2025-11-10 (Monday)61,747USD 59,687,120LLY holding increased by 2610046USD 59,687,1200USD 2,610,046 USD 966.64 USD 924.37
2025-11-07 (Friday)61,747USD 57,077,074LLY holding decreased by -807034USD 57,077,0740USD -807,034 USD 924.37 USD 937.44
2025-11-06 (Thursday)61,747USD 57,884,108LLY holding increased by 718118USD 57,884,1080USD 718,118 USD 937.44 USD 925.81
2025-11-05 (Wednesday)61,747LLY holding increased by 1474USD 57,165,990LLY holding increased by 2506817USD 57,165,9901,474USD 2,506,817 USD 925.81 USD 906.86
2025-11-04 (Tuesday)60,273LLY holding increased by 1472USD 54,659,173LLY holding increased by 1942312USD 54,659,1731,472USD 1,942,312 USD 906.86 USD 896.53
2025-11-03 (Monday)58,801USD 52,716,861LLY holding increased by 1979830USD 52,716,8610USD 1,979,830 USD 896.53 USD 862.86
2025-10-31 (Friday)58,801USD 50,737,031LLY holding increased by 1079586USD 50,737,0310USD 1,079,586 USD 862.86 USD 844.5
2025-10-30 (Thursday)58,801USD 49,657,445LLY holding increased by 1821067USD 49,657,4450USD 1,821,067 USD 844.5 USD 813.53
2025-10-29 (Wednesday)58,801LLY holding increased by 738USD 47,836,378LLY holding increased by 218912USD 47,836,378738USD 218,912 USD 813.53 USD 820.1
2025-10-28 (Tuesday)58,063LLY holding increased by 1476USD 47,617,466LLY holding increased by 853403USD 47,617,4661,476USD 853,403 USD 820.1 USD 826.41
2025-10-27 (Monday)56,587USD 46,764,063LLY holding increased by 54324USD 46,764,0630USD 54,324 USD 826.41 USD 825.45
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00BJ5JNZ06

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-05BUY1,474955.410908.230 912.948EUR 1,345,685 804.83
2025-11-04BUY1,472915.220883.640 886.798EUR 1,305,367 804.36
2025-10-29BUY738813.530830.290 828.614EUR 611,517 803.42
2025-10-28BUY1,476820.100829.460 828.524EUR 1,222,901 803.35
2025-10-20SELL-738808.960809.410 809.365EUR -597,311 802.99 Loss of -4,707 on sale
2025-10-16BUY737819.380834.700 833.168EUR 614,045 802.91
2025-10-07BUY1,472843.630848.540 848.049EUR 1,248,328 802.54
2025-09-26BUY2,205724.540729.000 728.554EUR 1,606,462 802.92
2025-09-11SELL-1,470756.280761.130 760.645EUR -1,118,148 805.17 Profit of 65,457 on sale
2025-09-09SELL-3,675750.610752.840 752.617EUR -2,765,868 805.75 Profit of 195,246 on sale
2025-09-04SELL-1,470742.910747.000 746.591EUR -1,097,489 806.90 Profit of 88,650 on sale
2025-08-26BUY134736.030736.180 736.165EUR 98,646 808.55
2025-07-07SELL-1,468772.870781.150 780.322EUR -1,145,513 812.90 Profit of 47,827 on sale
2025-06-17BUY735791.240805.160 803.768EUR 590,769 815.61
2025-06-02SELL-2,948747.120747.370 747.345EUR -2,203,173 818.05 Profit of 208,443 on sale
2025-05-30BUY6,954737.670745.900 745.077EUR 5,181,266 818.63
2025-04-29BUY108885.200892.470 891.743EUR 96,308 829.93
2025-03-25BUY650852.350874.920 872.663EUR 567,231 837.75
2025-03-07SELL-1,303869.580908.000 904.158EUR -1,178,118 838.53 Loss of -85,509 on sale
2025-03-04SELL-653911.060929.160 927.350EUR -605,560 836.46 Loss of -59,351 on sale
2025-02-28BUY10,551920.630921.220 921.161EUR 9,719,169 834.16
2025-02-25SELL-531901.800912.000 910.980EUR -483,730 831.19 Loss of -42,368 on sale
2025-02-20SELL-531873.120880.320 879.600EUR -467,068 829.29 Loss of -26,712 on sale
2025-02-18SELL-531857.200862.730 862.177EUR -457,816 828.34 Loss of -17,966 on sale
2025-02-04BUY97826.070829.040 828.743EUR 80,388 823.25
2025-01-02SELL-743778.070787.000 786.107EUR -584,078 827.59 Profit of 30,820 on sale
2024-12-10SELL-533799.580814.000 812.558EUR -433,093 828.16 Profit of 8,316 on sale
2024-12-03SELL-533813.330817.130 816.750EUR -435,328 829.11 Profit of 6,587 on sale
2024-11-29SELL-533795.350800.330 799.832EUR -426,310 830.61 Profit of 16,404 on sale
2024-11-25BUY5,947755.000755.000 755.000EUR 4,489,985 837.18
2024-11-22SELL-1,872748.010761.280 759.953EUR -1,422,632 839.65 Profit of 149,201 on sale
2024-11-19SELL-467729.730730.000 729.973EUR -340,897 848.32 Profit of 55,267 on sale
2024-11-18SELL-1,868727.200734.000 733.320EUR -1,369,842 852.10 Profit of 221,887 on sale
2024-10-24SELL-934891.320900.000 899.132EUR -839,789 906.18 Profit of 6,580 on sale
2024-10-24SELL-934891.320900.000 899.132EUR -839,789 906.18 Profit of 6,580 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.